DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/nm6nz9/cephalosporin) has announced the addition of the "Cephalosporin Markets in China - 2015 Edition" report to their offering.
China's demand for Cephalosporin has grown at a fast pace in the past decade. In the next decade, both production and demand will continue to grow. The Chinese economy maintains a high speed growth which has been stimulated by the consecutive increases of industrial output, imports & exports, consumer consumption and capital investment for over two decades.
This new study examines China's economic trends, investment environment, industry development, supply and demand, industry capacity, industry structure, marketing channels and major industry participants. Historical data (2004, 2009 and 2014) and long-term forecasts through 2019 and 2024 are presented.
Major producers in China are profiled. A selection of these companies can be seen in the 'Companies Mentioned' tab. The full list can be viewed upon purchase of the report.
Key Topics Covered:
II. BUSINESS ENVIRONMENT
III. CEPHALOSPORIN INDUSTRY ASSESSMENTS
IV. CEPHALOSPORIN PRODUCTION AND DEMAND
- Cefazolin Sodium
- Cefuroxime (sodium / ester)
- Cefoperazone Sodium
- Cefoperazone Sodium and Sulbactam Sodium
- Cefetamet Pivoxil
V. CHINA CEPHALOSPORIN MARKETS OUTLOOK
VI. MARKET ENTRY CHANNELS
VII. CEPHALOSPORIN PRODUCER DIRECTORY
- Shanxi Weiqida Pharmaceutical Co., Ltd.
For more information visit http://www.researchandmarkets.com/research/nm6nz9/cephalosporin